Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Stress Urinary Incontinence in Elite Athletes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03938779
Recruitment Status : Unknown
Verified July 2019 by Telma Pires, University of Trás-os-Montes and Alto Douro.
Recruitment status was:  Recruiting
First Posted : May 6, 2019
Last Update Posted : July 8, 2019
Sponsor:
Information provided by (Responsible Party):
Telma Pires, University of Trás-os-Montes and Alto Douro

Brief Summary:
A protocol of pelvic floor muscles training (PFMT) in elite athletes was applied. They will do it for 4 months. Then re-evaluated.

Condition or disease Intervention/treatment Phase
Pelvic Floor Disorders Behavioral: Pelvic Floor Muscle Training (PFMT) Diagnostic Test: Pad test Not Applicable

Detailed Description:
The athletes of the Portuguese national female's volleyball team were evaluated through perineometry, pad-test and Kings health questionnaire. They were taught a plan of pelvic floor muscles training (PFMT) to perform for 4 months. After this time they will be re-evaluated with the same measuring instruments.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 15 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Intervention Model Description: Volleyball team will be evaluated in two moments, at the beginning and 4 months after the PFMT. After 4 months, to compare with the control group and to evaluate if there are differences between groups, namely muscle strength
Masking: Single (Participant)
Masking Description: The participants do not know that there is a control group and an intervention group
Primary Purpose: Treatment
Official Title: Pelvic Floor Muscle Training and Stress Urinary Incontinence in Elite Athletes . Clinical Trial
Actual Study Start Date : April 25, 2019
Actual Primary Completion Date : April 25, 2019
Estimated Study Completion Date : August 4, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Pelvic Floor Muscle Training (PFMT)
Experimental group will perform for 4 months a PFMT
Behavioral: Pelvic Floor Muscle Training (PFMT)
PFMT is a protocol of exercises for prevention and treatment for Stress Urinary Incontinence in elite females athletes, volleyball team

Experimental: Pad test
The experimental and control group will perform the pad test twice. At the beginning of the evaluation and 4 months after the PFMT. The modified pad test, has the durability of a workout (2h30min)
Diagnostic Test: Pad test
Pad test is a standardised test for quantifying urine loss. Pad test is not invasive and provide an easy, inexpensive and objective assessment of urine loss.

No Intervention: Kings Health Questionnaire
Kings Health Questionnaire to assess the impact of urinary incontinence on quality of life of women. Both groups will complete the questionnaire.
No Intervention: perineometer
Both groups will perform perineometry at baseline and 4 months after



Primary Outcome Measures :
  1. Pad-test (Short-term) [ Time Frame: 2 hour 30 min ]
    The pad test is a standardised test for quantifying urine loss.


Other Outcome Measures:
  1. Kings Health Questionnaire (KHQ) [ Time Frame: 10 minutes ]
    Was constructed in order to assess the impact of urinary incontinence on quality of life women, also evaluating urinary symptoms and subjective measures of severity. The KHQ is composed of 21 items investigating nine domains and it evaluates the agreement of the subjects on a 4- and 5- option Likert scale: general health perceptions (1item), incontinence impact (1 item), role limitations (2 items), physical limitations (2 items), social limitations (2 items), personal relationships (3 items), emotions (3 items), sleep and energy (2 items) and severity measures (5 items). Additionally, it has an independent subscale designed as a Symptom Severity Scale, which contains 11 items, measuring the presence and severity of urinary symptoms (Appendix 5). The KHQ scored from a minimum of 0 (best QoL) to a maximum of 100 (worst QoL), scored by every domain and by their global score. Scores of independent subscale (Symptom Severity Scale) was calculated in the same way.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   15 Years to 30 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Women have a predisposition to stress urinary incontinence, caused by high-impact exercises
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Elite female athletes
  • Nulliparous
  • Volleyball team.

Exclusion Criteria:

  • Inability to contract the PFM, elderly
  • Prolapse of the pelvic organs.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03938779


Contacts
Layout table for location contacts
Contact: Telma F Pires, MSc +351 936 972 003 telmafilipapires@gmail.com
Contact: UTAD UTAD +351 259 350 000

Locations
Layout table for location information
Portugal
Telma Filipa Rodrigues Pereira Pires Recruiting
Vila Real, Trás-os-Montes E Alto Douro, Portugal, 5000-438
Contact: Telma Pires, MSc    (+351) 936 972 003    telmafilipapires@gmail.com   
Contact: UTAD    (+351) 259 350 000      
Sub-Investigator: Patrícia Pires, MSc         
Sub-Investigator: Helena Moreira, Dr         
Sub-Investigator: Paulo Vicente, Dr         
Sub-Investigator: Sara Viana, Dr         
Sub-Investigator: Rui Viana, Dr         
Sponsors and Collaborators
University of Trás-os-Montes and Alto Douro
Publications of Results:
Layout table for additonal information
Responsible Party: Telma Pires, principal investigator, University of Trás-os-Montes and Alto Douro
ClinicalTrials.gov Identifier: NCT03938779    
Other Study ID Numbers: 25/2017
First Posted: May 6, 2019    Key Record Dates
Last Update Posted: July 8, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: Urinary incontinence is a public health problem, which we must combat intervention measures and publication of clinical trials to prevent and treat urinary incontinence. The PFMT is the first line treatment advised by recent literature.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Telma Pires, University of Trás-os-Montes and Alto Douro:
Elite Athletes
Volleyball
Pelvic Floor Muscle Training
Additional relevant MeSH terms:
Layout table for MeSH terms
Urinary Incontinence
Enuresis
Urinary Incontinence, Stress
Pelvic Floor Disorders
Urination Disorders
Urologic Diseases
Lower Urinary Tract Symptoms
Urological Manifestations
Behavioral Symptoms
Elimination Disorders
Mental Disorders
Pregnancy Complications